Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Lithium chloride
RN: 7447-41-8
UNII: G4962QA067
InChIKey: KWGKDLIKAYFUFQ-UHFFFAOYSA-M

Note

  • A salt of lithium that has been used experimentally as an immunomodulator.

Molecular Formula

  • Cl-Li

Molecular Weight

  • 42.394
 

Classification Codes

  • Adjuvants, Immunologic
  • Antimanic Agents
  • Central Nervous System Agents
  • Central Nervous System Depressants
  • Drug / Therapeutic Agent
  • Human Data
  • Immunologic Factors
  • Mutation Data
  • Psychotropic Drugs
  • Reproductive Effect
  • Skin / Eye Irritant
  • Tranquilizing Agents
  • Tumor Data
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Lithium chloride

MeSH Heading

  • Lithium chloride

Synonyms

  • CCRIS 5924
  • Chlorku litu
  • Chlorku litu [Polish]
  • Chlorure de lithium
  • Chlorure de lithium [French]
  • EC 231-212-3
  • EINECS 231-212-3
  • HSDB 4281
  • Lithium chloride
  • NSC 327172
  • UNII-G4962QA067

Systematic Names

  • Lithium chloride
  • Lithium chloride (LiCl)

Superlist Name

  • Luthium chloride

Registry Numbers

CAS Registry Number

  • 7447-41-8

FDA UNII

  • G4962QA067

Other Registry Numbers

  • 1220508-63-3
  • 1309791-76-1
  • 2018280-04-9
  • 404596-80-1

System Generated Number

  • 0007447418

Structure Descriptors

InChI

InChI=1S/ClH.Li/h1H;/q;+1/p-1

InChIKey

KWGKDLIKAYFUFQ-UHFFFAOYSA-M

Smiles

[Li]Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
bird - wild LD50 oral 422mg/kg (422mg/kg)   Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983.
cat LD50 intraperitoneal 492mg/kg (492mg/kg)   Russian Pharmacology and Toxicology Vol. 42, Pg. 9, 1979.
cat LDLo subcutaneous 450mg/kg (450mg/kg)   Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975.
dog LDLo intravenous 500mg/kg (500mg/kg) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

MUSCULOSKELETAL: OTHER CHANGES

BEHAVIORAL: FOOD INTAKE (ANIMAL)		 Journal of Pharmacology and Experimental Therapeutics. Vol. 100, Pg. 429, 1950.
frog LDLo subcutaneous 885mg/kg (885mg/kg)   "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.
guinea pig LD50 intraperitoneal 624mg/kg (624mg/kg)   "Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 157, 1999.
guinea pig LDLo subcutaneous 620mg/kg (620mg/kg)   Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975.
human LDLo oral 200mg/kg/3D (200mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)

BEHAVIORAL: MUSCLE WEAKNESS		 JAMA, Journal of the American Medical Association. Vol. 139, Pg. 688, 1949.
human TDLo oral 243mg/kg/13D (243mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: TREMOR		 JAMA, Journal of the American Medical Association. Vol. 139, Pg. 688, 1949.
mouse LD50 intracrebral 14040ug/kg (14.04mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)		 Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 69, Pg. 75, 1973.
mouse LD50 intraperitoneal 600mg/kg (600mg/kg)   Journal of Thermal Biology. Vol. 6, Pg. 87, 1981.
mouse LD50 intravenous 363mg/kg (363mg/kg) BEHAVIORAL: ANTIPSYCHOTIC

BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS		 Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 413, 1973.
mouse LD50 oral 1165mg/kg (1165mg/kg)   Russian Pharmacology and Toxicology Vol. 33, Pg. 266, 1970.
mouse LD50 subcutaneous 738mg/kg (738mg/kg) MUSCULOSKELETAL: OTHER CHANGES

BEHAVIORAL: TREMOR		 Acta Pharmacologica et Toxicologica. Vol. 43, Pg. 51, 1978.
pigeon LDLo subcutaneous 513mg/kg (513mg/kg)   "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.
quail LD50 oral 422mg/kg (422mg/kg)   Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983.
rabbit LD50 oral 800mg/kg (800mg/kg)   Farmakologiya i Toksikologiya Vol. 39, Pg. 53, 1976.
rabbit LDLo subcutaneous 531mg/kg (531mg/kg)   Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975.
rat LD50 intracrebral 4800ug/kg (4.8mg/kg)   Polish Journal of Pharmacology and Pharmacy. Vol. 26, Pg. 399, 1974.
rat LD50 intracrebral 4800ug/kg (4.8mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)		 Polish Journal of Pharmacology and Pharmacy. Vol. 26, Pg. 399, 1974.
rat LD50 intraperitoneal 514mg/kg (514mg/kg)   Personal Communication from K.P. Petersen, DAK Labs., 59 Lergravsvej, DK-2300, Copenhagen, Demark, Dec. 22, 1977Vol. 22DEC1977,
rat LD50 intratracheal 205mg/kg (205mg/kg)   "Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 157, 1999.
rat LD50 oral 526mg/kg (526mg/kg)   Acta Pharmacologica et Toxicologica. Vol. 47, Pg. 351, 1980.
rat LD50 subcutaneous 499mg/kg (499mg/kg)   Personal Communication from K.P. Petersen, DAK Labs., 59 Lergravsvej, DK-2300, Copenhagen, Demark, Dec. 22, 1977Vol. 22DEC1977,